We are live on ! Find out more
IMVT icon

Immunovant
IMVT

181 hedge funds and large institutions have $2.57B invested in Immunovant in 2023 Q3 according to their latest regulatory filings, with 61 funds opening new positions, 64 increasing their positions, 44 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more funds holding in top 10

Funds holding in top 10: 3 → 12 (+9)

154% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 24

144% more capital invested

Capital invested by funds: $1.05B → $2.57B (+$1.52B)

45% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 44

23% more funds holding

Funds holding: 147 → 181 (+34)

8.66% more ownership

Funds ownership: 42.53% → 51.19% (+8.7%)

46% less call options, than puts

Call options by funds: $136M | Put options by funds: $252M

Holders
181
Holders Change
+34
Holders Change %
+23.13%
% of All Funds
2.87%
Holding in Top 10
12
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+300%
% of All Funds
0.19%
New
61
Increased
64
Reduced
44
Closed
24
Calls
$136M
Puts
$252M
Net Calls
-$116M
Net Calls Change
-$121M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$56.4M
2
DGM
Darwin Global Management
Jersey
+$41.1M
3
PA
Perceptive Advisors
New York
+$29.2M
4
FAM
Fred Alger Management
New York
+$26.4M
5
AC
Armistice Capital
New York
+$23.4M

Top Sellers

1
DTC
Deep Track Capital
Connecticut
-$59.3M
2
APM
Avidity Partners Management
Texas
-$20.6M
3
RG
Redmile Group
California
-$18.5M
4
Two Sigma Investments
Two Sigma Investments
New York
-$15M
5
LGM
Logos Global Management
California
-$14.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
Russell Investments Group
101
Russell Investments Group
United Kingdom
$1.55M +$915K +40,483 New
Royal Bank of Canada
102
Royal Bank of Canada
Ontario, Canada
$1.54M +$807K +35,692 +821%
AA
103
AlphaCentric Advisors
Puerto Rico
$1.46M +$859K +38,000 New
Mirae Asset Global Investments
104
Mirae Asset Global Investments
South Korea
$1.44M +$23.9K +1,059 +3%
Janus Henderson Group
105
Janus Henderson Group
United Kingdom
$1.4M +$450K +19,900 +121%
Deutsche Bank
106
Deutsche Bank
Germany
$1.34M -$2.43M -107,689 -75%
DekaBank Deutsche Girozentrale
107
DekaBank Deutsche Girozentrale
Germany
$1.3M – – –
SO
108
STRS Ohio
Ohio
$1.29M -$54.2K -2,400 -7%
TD Asset Management
109
TD Asset Management
Ontario, Canada
$1.2M +$705K +31,200 New
WMSA
110
Weiss Multi-Strategy Advisers
New York
$1.18M -$2.31M -102,174 -77%
Walleye Capital
111
Walleye Capital
New York
$1.17M +$689K +30,462 New
New York State Common Retirement Fund
112
New York State Common Retirement Fund
New York
$1.15M +$191K +8,470 +40%
Envestnet Asset Management
113
Envestnet Asset Management
Illinois
$1.1M +$646K +28,586 New
MIM
114
MetLife Investment Management
New Jersey
$1.09M – – –
AIG
115
American International Group
New York
$1.03M +$21.6K +957 +4%
AQR Capital Management
116
AQR Capital Management
Connecticut
$986K -$781K -34,532 -57%
Prudential Financial
117
Prudential Financial
New Jersey
$954K -$1.09M -48,400 -66%
HighTower Advisors
118
HighTower Advisors
Illinois
$933K +$1.72K +76 +0.3%
CIP
119
Chartwell Investment Partners
Pennsylvania
$887K – – –
NYLIM
120
New York Life Investment Management
New York
$880K -$82.5K -3,652 -14%
DCM
121
DAFNA Capital Management
California
$864K +$509K +22,500 New
YIH
122
Y-Intercept (HK)
Hong Kong
$847K +$499K +22,060 New
CAM
123
ClariVest Asset Management
California
$821K – – –
SEI Investments
124
SEI Investments
Pennsylvania
$733K +$432K +19,102 New
ASRS
125
Arizona State Retirement System
Arizona
$642K +$47.4K +2,095 +14%
3 4
5
6 7

IMVT Hedge Fund Activity: Q3 2023 in Review

181 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Immunovant (IMVT) for Q3 2023, worth a combined $2.57B — up 144% from $1.05B a quarter earlier.

Buyers outnumbered sellers: 61 funds opened new IMVT positions and 24 closed out — a net gain of 37 holders — while 64 added to existing stakes and 44 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $56.4M. The largest seller was Deep Track Capital, cutting an estimated $59.3M.

  • 181 institutional investors held Immunovant (IMVT) as of Q3 2023, up from 147 in Q2 2023.
  • Funds reported $2.57B of Immunovant stock for Q3 2023, up 144% quarter-over-quarter.
  • 61 funds opened new Immunovant positions in Q3 2023 and 24 closed out, a net change of +37 holders.
  • The largest Immunovant buyer in Q3 2023 was Fidelity Investments, an estimated $56.4M added.
  • The largest Immunovant seller in Q3 2023 was Deep Track Capital, an estimated $59.3M sold.

Based on aggregated 13F filings for Q3 2023.